Allergan Inc.’s consolidated patent infringement actions against Barr Laboratories, Inc. and Sandoz, Inc. remain pending.
In March 2009, the Company received a paragraph 4 invalidity and non-infringement Hatch-Waxman Act certification from…
Allergan Inc.’s consolidated patent infringement actions against Hi-Tech Pharmacal Co., Sandoz, Inc. and Alcon Research, Ltd. remain pending.
Allergan Inc.’s consolidated patent infringement actions against Hi-Tech Pharmacal Co., Sandoz, Inc. and…
Merck & Co., Inc.’s patent infringement suit against Sandoz Inc. is scheduled to go to trial in December 2010.
In January 2009, the company received notice from Sandoz that it had…
Genzyme Corporation is engaged in dispute with Sandoz, Inc., over infringement of the Renagel patent.
The company on July 2, 2009, filed a complaint against Sandoz in the U.S. District Court…
Allergan Inc. pursues a patent infringement complaint against Sandoz, Inc., in the U.S. District Court for the Eastern District of Texas.
In February 2009, the Company received paragraph 4 invalidity and…
Wyeth and its licensing partner, Nycomed GmbH, are pursuing a lawsuit against Sandoz Inc. in the U.S. District Court for the Northern District of Illinois, alleging infringement of U.S. Patent…
Wyeth pursues a lawsuit against Sandoz Inc. in the U.S. District Court for the District of Delaware, alleging that Sandoz’s filing of Abbreviated New Drug Application with the U.S. Food…
The U.S. District Court for the District of Colorado has not yet ruled on the summary judgment motions filed in Shire Ltd.’s suit against Sandoz Inc. for the alleged infringement…
Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., continues to be in a dispute with Sandoz Inc. over its challenges to the RAZADYNE(R) ER patents.
In the action against Sandoz with respect…